Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease

Creative Commons License

Diller G., Dimopoulos K., KAYA M. G., Harries C., Uebing A., Li W., ...Daha Fazla

HEART, cilt.93, sa.8, ss.974-976, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 93 Sayı: 8
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1136/hrt.2006.089185
  • Dergi Adı: HEART
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.974-976
  • Erciyes Üniversitesi Adresli: Evet

Özet

Objective: To examine long-term safety and efficacy of bosentan - an oral dual endothelin receptor antagonist - in patients with pulmonary hypertension associated with congenital heart disease or Eisenmenger's syndrome.